Showing 74,921 - 74,940 results of 120,802 for search '(( 5 ((a decrease) OR (nn decrease)) ) OR ( a ((mean decrease) OR (fold decrease)) ))', query time: 1.94s Refine Results
  1. 74921

    AnsB activity required for <i>S. flexneri</i>-mediated killing and bacterial accumulation in <i>C. elegans</i>. by Divya T. George (555316)

    Published 2014
    “…Diluted lysates were plated on LB agar plates carrying appropriate antibiotics, and colonies were scored in order to quantify <i>S. flexneri</i> cells associated with each nematode. There is a significant decrease in the accumulation of SFL2283 compared to SFL1520 and SFL2309 (<i>p</i><0.01, One-way ANOVA). …”
  2. 74922

    Validation of miR-25 targets. by Dong Lu (141452)

    Published 2012
    “…A significant decrease of <i>Wwp2</i> was detected in 25-iPSCs, compared to 4F-iPSCs. …”
  3. 74923

    Data_Sheet_1_Digital Communication Biomarkers of Mood and Diagnosis in Borderline Personality Disorder, Bipolar Disorder, and Healthy Control Populations.docx by George Gillett (10538903)

    Published 2021
    “…Depression in BD, but not BPD, was associated with decreased total and outgoing call frequency, mean total and outgoing call duration and total and outgoing SMS frequency. …”
  4. 74924

    Effect of LPCAT1 knockdown on OSCC-derived cell lines. by Tomomi Shida-Sakazume (710302)

    Published 2015
    “…To evaluate the effect of LPCAT1 knockdown on invasiveness, we seeded 2.5×10<sup>5</sup> cells in the serum-free medium of a 0.8-μm polyethylene terephthalate membrane insert in a transwell apparatus and added serum-supplemented medium in the lower chamber as a chemoattractant. …”
  5. 74925

    Immunoglobulins and non-categorized immune genes exhibiting differential expression between resistant and susceptible birds. by Sarah Connell (147307)

    Published 2012
    “…<p>Genes are ordered according to fold-difference and the direction of fold-difference is shown to indicate either increased (+) or decreased (−) expression in resistant relative to susceptible birds. …”
  6. 74926

    PBA stimulation of APPGV16 requires secretase processing. by Jesse C. Wiley (234079)

    Published 2010
    “…However, co-treatment with GM6001 or TAPI-II decreased the fold-stimulation by approximately half (p<0.0001; two-way ANOVA). …”
  7. 74927

    Assessment of soluble receptors and related proteins from non-hematopoietic cells in patients with CFLD (Array B). by Timo Rath (389419)

    Published 2013
    “…ADAM10, BACE-1, CD23, CD147, RECK, TNFRII were at least 2-fold increased in CFLD whereas ITGB3 was at least 2-fold decreased in patients with CFLD compared to those without (C). …”
  8. 74928

    Effects of resistance exercise versus combined training on post-exercise hypotension in women with metabolic syndrome by Ramires Alsamir Tibana (8977688)

    Published 2022
    “…Therefore, RE and COMB elicited post-exercise hypotension in women with MS; COMB provided a greater decrease which may be of value in the prevention and treatment of cardiovascular disorders.…”
  9. 74929
  10. 74930

    Table_1_The Increased Expression of an Engrailed to Sustain Shell Formation in Response to Ocean Acidification.DOCX by Yukun Zhang (705103)

    Published 2020
    “…The mRNA expression of Cgengrailed-1 in mantle decreased dramatically after moderate (pH 7.8) and severe (pH 7.4) acidification treatment (0.75- and 0.15-fold of that in control group, p < 0.05). …”
  11. 74931

    Image_1_The Increased Expression of an Engrailed to Sustain Shell Formation in Response to Ocean Acidification.JPEG by Yukun Zhang (705103)

    Published 2020
    “…The mRNA expression of Cgengrailed-1 in mantle decreased dramatically after moderate (pH 7.8) and severe (pH 7.4) acidification treatment (0.75- and 0.15-fold of that in control group, p < 0.05). …”
  12. 74932

    Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  13. 74933

    DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  14. 74934

    Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  15. 74935

    Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  16. 74936

    DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  17. 74937

    Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  18. 74938

    Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  19. 74939

    DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
  20. 74940

    Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

    Published 2021
    “…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”